Organ donation: Opt-out defaults do not increase donation rates
Peer-Reviewed Publication
Updates every hour. Last Updated: 8-May-2025 23:09 ET (9-May-2025 03:09 GMT/UTC)
A recent study by the Max Planck Institute for Human Development, in collaboration with the MSB Medical School Berlin and the Max Planck UCL Centre for Computational Psychiatry and Ageing Research, shows that switching to an opt-out organ donation policy, where all adults are presumed organ donors unless they explicitly opt out, does not increase donations from deceased donors. The results of the study have been published in the journal Public Health.
The predominant treatment for prostate cancer, a prevalent malignancy in men, is the surgical removal of the prostate (radical prostatectomy) for which biopsy is a prerequisite. However, the high costs and associated complications of biopsy impose financial and health burdens on patients. A new study developed a diagnostic strategy for patients with prostate cancer to undergo radical prostatectomy without the need for biopsy, potentially decreasing hospital stay duration and reduced expenditure for patients.
Dr. Etienne Sibille's journey from art galleries and photojournalism agencies to neuroscience leader exemplifies the power of unconventional paths in scientific innovation. Now directing groundbreaking research at the University of Toronto and CAMH and drug development R&D as co-founder and Chief Scientific Officer of Damona Pharmaceuticals, his work on depression and brain aging bridges laboratory discoveries with therapeutic development, while his artistic background brings fresh perspectives to complex neuropsychiatric challenges.